GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer

Clinical trial NCT00320411 · COMPLETED

Trial details

NCT number: NCT00320411
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neoplasms, Breast

Start date: 2005-11-28
Primary completion: 2009-04-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.